Esomeprazole is a proton pump inhibitor that inhibits the major release of acid associated with covalent binding to the H + / K + ATPase enzyme system located in gastric parietal cells. Esomeprazole is Originally available in tablet, capsule, injection and powder form.
Esomeprazole IV Injection is a combination pack consisting of a vial containing lyophilized powder of Esomeprazole 20 mg Tablet, Sodium and a separate ampoule of 5 ml Sodium Chloride BP 0.9 % Injection as reconstituting solution. Its blocks the final step in acid production thus reducing gastric acidity.
Esomeprazole is used to treat gastroesophageal reflux disease, erosive esophagitis, in-steroidal anti-inflammatory, acid-related dyspepsia, duodenal or gastric ulcer. It is also indicated as a supplement and in the treatment of infections caused by the following. E.g.
Healing of Erosive Esophagitis: 20-40 mg once daily for 4-8 weeks. If not healed an additional 4-8 weeks of treatment may be considered.
Maintenance of Healing of Erosive Esophagitis: 20 mg once daily (controlled studies have not exceeded 6 months).
Symptomatic Gastroesophageal Reflux Disease: 20 mg once daily for 4 weeks. If symptoms persist an additional 4 weeks of treatment may be considered.
Duodenal Ulcers: Daily 20 mg, 2-4 weeks.
Gastric Ulcer: Daily 20/40 mg, 4-6 weeks.
Triple therapy to eliminate Helicobacter pylori in duodenal ulcers:
Children: Short-term treatment of GERD.
Injection: Gastroesophageal Reflux Disease: For short-term treatment of adult GERD patients with a history of Erosive Esophagitis (EE) as an alternative to oral therapy. Treatment with Esomeprazole IV Injection should be discontinued as soon as the patient is able to continue treatment with Esomeprazole Tablet or Capsule.
IV injection must be administered intravenously over a period of at least 3 minutes. Half of the IV injection should be used when 20 mg is to be administered. The prepared solution must be used within 12 hours of preparation and can be exposed to normal indoor lighting at a maximum of 30° C.
This Tablet should be taken 1 hour before meals. The recommended dosage and application rules may vary depending on the type of disease. Esomeprazole or any of the components of this preparation should not be used in patients with hypersensitivity. It is advisable to consult a medical specialist before using the tablet.
Esomeprazole is to alleviate gastroesophageal reflux disease, erosive esophagitis, erosive esophagitis as a maintenance dose, alleviate symptoms of gastroesophageal reflux, in-steroidal anti-inflammatory, helicobacter therapeutic. This drug is mainly used to relieve some of these problems.
Esomeprazole cytochrome P450 reduces the effectiveness of the mono-oxygenation system. Therefore, there may be a reaction in the case of excretion through the liver, but so far no evidence of a reaction has been found. It should have a sudden reaction to the oral contraceptive pill. The physiological changes that occur with the use of omeprazole due to decreased acid secretion,
It can also occur in Esomeprazole and may interfere with the colonization of bacteria and absorption of vitamin B-12 in the stomach and duodenum. There is no evidence of interaction of phenytoin, warfarin, quinidine, clarithromycin, amoxicillin during the use of Esomeprazole.
However, the use of Esomeprazole with diazepam may delay the secretion of diazepam. It may interfere with the absorption of ketoconazole, digoxin, and iron drugs.
It is contraindicated in patients with known hypersensitivity to Esomeprazole or to substituted benzimidazoles.
Esomeprazole may cause some mild and temporary side effects while taking the medicine.
After an intense overdose, nausea, vomiting, and diarrhea cause diarrhea, although neuromuscular hyperSecency and seizures arise. It should not be used for ultimate patients in any element of IsomiPazil or this stone. Since it may cause negative feedback for these patients, you are Esomeprazole. Consult your doctor before starting the tablet’s prescription.
In the research on pregnant animals, there is no harmful effect on Esomeprazole. However, there was no significant research on pregnant mothers. There was no scalable result in testing on animals. If we need too much, it should be used during pregnancy. Since there is no impact on the emission of newborn children.
In the presence of any alarming symptom (e.g. significant unintentional weight loss, recurrent vomiting, dysphagia, haematemesis, or melena) and when gastric ulcer is suspected or present. The possibility of malignancy should be excluded.
Because treatment with Esomeprazole may alleviate symptoms and delay diagnosis, patients on long-term treatment should be kept under regular surveillance. When prescribing Esomeprazolet with other antibiotics for the eradication of H. pylori, the risk of drug interaction should be considered.
Store in a dry place at a temperature below 30°C, Protect from light and moisture. Keep out of reach of children.